Revolution Medicines, Inc. Common Stock (RVMD) is a publicly traded Healthcare sector company. As of October 3, 2026, RVMD trades at $206.15 with a market cap of $44.29B and a P/E ratio of -34.92. RVMD moved +0.37% today. Year to date, RVMD is +161.50%; over the trailing twelve months it is +352.17%. Its 52-week range spans $29.17 to $224.31. Analyst consensus is strong buy with an average price target of $254.80. Rallies surfaces RVMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
22 analysts cover RVMD: 0 strong buy, 21 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $254.80.
| Metric | Value |
|---|---|
| Price | $206.15 |
| Market Cap | $44.29B |
| P/E Ratio | -34.92 |
| EPS | $-5.95 |
| Dividend Yield | 0.00% |
| 52-Week High | $224.31 |
| 52-Week Low | $29.17 |
| Volume | 1.36M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-1.13B |
| Gross Margin | 0.00% |
22 analysts cover RVMD: 0 strong buy, 21 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $254.80.